<DOC>
	<DOCNO>NCT00941850</DOCNO>
	<brief_summary>Patients randomise receive ongoing optimise device medical therapy triple ventricular site resynchronisation . The hypothesis state patient receive triple-site resynchronization exhibit well response .</brief_summary>
	<brief_title>A Study Triple-site Ventricular Pacing Patients Who Have Not Responded Conventional Dual Ventricular Site Cardiac Resynchronization Therapy</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Implanted CRT device &gt; 6 month previously accord current conventional CRT indication Device optimization &gt; 1 month previously Aged 18yrs old Able attend outpatient follow Recent MI ( &lt; 2 month ) Women pregnant planning pregnancy Severe co morbid illness ( patient expect survive duration follow period repeat outpatient visit may best interest patient ) Upgrade procedure contraindicate safety reason . Class IV inotropic agent Patient unwilling comply require followup protocol include randomization scheme</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cardiac resynchronizton therapy</keyword>
	<keyword>CRT</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Dyssynchrony</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>Pacemakers</keyword>
	<keyword>Nonresponders</keyword>
</DOC>